The NYU Winthrop Hospital Institutional Review Board (NYUWH IRB) is the review board designated by the NYU Winthrop Hospital Executive Committee of the Medical Staff to review, approve the initiation of, and conduct ongoing review of research involving human subjects.
The primary purpose of the IRB is constituted in accordance with the code of Federal Regulations 21 CFR Part 50, 21 CFR Part 56 and 45 CFR Part 46. The NYUWH IRB hereby gives assurance that it shall comply with applicable New York State Law (Article 24-A of the New York State Public Health Law).
The NYU Winthrop Hospital IRB reviews all research projects including; projects eligible for exempt status, expedited status, Phase I and II clinical trials, both inpatient and outpatient pharmaceutically sponsored trials, all studies involving investigational devices, investigator-initiated trials, and federally sponsored projects. This site contains information for WUH IRB.
NYU Langone IRB Operations has relationships with several external IRBs, all of which are accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP). Using an external IRB requires prior clearance by the External Review Unit, please click here for information.